Results 91 to 100 of about 107,286 (246)

Particularities of rhythm and conduction disorders in heart failure patients with preserved ejection fraction admitted to a rehabilitation hospital [PDF]

open access: yesBalneo and PRM Research Journal
(1) Background: The mortality and prognosis of patients with heart failure with preserved ejection fraction have shown minimal improvement over the past 20 years, possibly since this condition is often accompanied by various other cardiovascular risk ...
Marius-Dragoș Mihăilă, Dana Pop
doaj   +1 more source

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial

open access: yesESC Heart Failure, 2022
Aims In the heart failure (HF) with preserved ejection fraction (HFpEF) PARAGON‐HF trial, sacubitril/valsartan vs. valsartan improved mortality/morbidity in patients with left ventricular ejection fraction (LVEF) below median (57%).
Lars H. Lund   +9 more
doaj   +1 more source

Living With Heart Failure With Preserved Ejection Fraction

open access: yesJACC: Heart Failure, 2017
I was diagnosed with heart failure with preserved ejection fraction (HFpEF) 2.5 years ago. After the initial shock of learning I have an untreatable and incurable heart disease, I settled into learning to live with the disease disrupting my life as little as possible, seeing my cardiologist ...
openaire   +2 more sources

Axial Muscle Size as a Strong Predictor of Death in Subjects With and Without Heart Failure

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background The impact of skeletal muscle size, quantified using simple noninvasive images routinely obtained during cardiac magnetic resonance imaging studies on mortality in the heart failure (HF) population is currently unknown.
Anupam Kumar   +11 more
doaj   +1 more source

Expression of epicardial adipose tissue thermogenic genes in patients with reduced and preserved ejection fraction heart failure [PDF]

open access: yes, 2017
[Abstract] Epicardial adipose tissue has been proposed to participate in the pathogenesis of heart failure. The aim of our study was to assess the expression of thermogenic genes (Uncoupling protein 1 (UCP1), peroxisome proliferator-activated receptor ...
Carrasco-Chinchilla, Fernando   +11 more
core   +5 more sources

Five-Year Outcomes of Heart Failure with Preserved Ejection Fraction [PDF]

open access: diamond, 2020
Cristina Macía-Rodríguez   +7 more
openalex   +1 more source

Prediction models and risk scores in different types of heart failure: a review

open access: yesFrontiers in Medicine
BackgroundHeart failure (HF) is a leading cause of global disease burden and mortality. Accurate prognosis assessment is critical for reducing the risk of adverse events.
Yue Wei   +7 more
doaj   +1 more source

The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study [PDF]

open access: yes, 2014
Background Nationally, symptomatic heart failure affects 1.5-2% of Canadians, incurs $3 billion in hospital costs annually and the global burden is expected to double in the next 1–2 decades.
Anderson, Todd J.   +23 more
core   +1 more source

Cardiovascular diseases and comorbidity in patients with chronic heart failure and preserved ejection fraction depending on age [PDF]

open access: yes, 2017
The aim of the study was to determine the cardiovascular dis) eases and comorbidity in patients with chronic heart failure and preserved ejection fraction depending on age.
Dobrohorska, H.O.   +2 more
core  

Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction [PDF]

open access: yes, 2018
Aims: The mechanisms of exercise intolerance in heart failure with preserved ejection fraction (HFpEF) are not yet elucidated. Chronotropic incompetence has emerged as a potential mechanism.
Bellver, Alejandro   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy